Skip Navigation

COVID-19 Update

We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Please know that our vaccine supply is extremely small. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts


Kenneth Pienta Laboratory

Led by Kenneth Pienta, M.D., the Pienta Laboratory is focused on research to define the tumor microenvironment as well as develop new therapies for prostate cancer. Dr. Pienta utilizes the principles of ecology and evolutionary dynamics to study cancer.

Between 1995 and 2013, Dr. Pienta was the director of the Prostate Specialized Program of Research Excellence (SPORE) at the University of Michigan and from 2013-present he has been co-Director of the Prostate SPORE at Johns Hopkins. He has been continuously funded by the NIH since 1991 and has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development and clinical application. 

Dr. Pienta has international expertise in the development of novel chemotherapeutic programs for cancer and has championed the concept that translational research is often best accomplished by multidisciplinary teams of scientists and clinicians.

He is the author of more than 500 peer-reviewed articles and been the principal investigator on numerous local and national clinical trials. Throughout his career, Dr. Pienta has effectively mentored more than 50 students, residents and fellows to successful careers in medicine.



back to top button